ViewRay appoints Scott Drake as chief executive officer
Staff Writer |
Cleveland, Oh., USA - ViewRay, maker of the MRI-guided radiation therapy system, announced the appointment of Scott Drake as its president and chief executive officer and Shar Matin as its chief operating officer.
Article continues below
In connection with his appointment, Mr. Drake has also been appointed to the ViewRay Board of Directors.
Scott Drake formerly served as the President and Chief Executive Officer of the Spectranetics Corporation.
Mr. Drake currently serves as the Chairman of the Board of Directors for AtriCure and as the Chairman of the Board of Directors for JustRight Surgical.
Before joining Spectranetics, he served as Senior Vice President for DaVita Corporation.
He also previously worked at Covidien (now part of Medtronic) from 1992 until 2009.
Mr. Drake graduated from the Miami University of Ohio with a Bachelor of Science in Business.
Shar Matin previously worked for Spectranetics starting in 2007, serving as its Chief Operating Officer from 2014 until its acquisition by Royal Philips in 2017.
Before joining Spectranetics, he worked for the Guidant Corporation (now Boston Scientific Corporation) in various commercial and engineering roles from 1997 until 2007.
Mr. Matin graduated from Harvard Business School with a Master in Business Administration, and graduated from the University of California, Berkeley with honors with a Bachelor of Science in Mechanical Engineering.
In addition, ViewRay announced the appointment of D. Keith Grossman to the ViewRay Board of Directors.
D. Keith Grossman previously served as the President, Chief Executive Officer and Director for Thoratec Corporation through its $3.4 billion acquisition by St. Jude Medical (now Abbott Laboratories) in 2016.
From 2011 to 2013, Mr. Grossman served as President, Chief Executive Officer and Director for Conceptus, where he led its turnaround and acquisition by Bayer Healthcare in 2013.
From 2007 to 2011, he served as a Managing Director with the Texas Pacific Group, a private equity firm, in their healthcare investment team.
Mr. Grossman currently serves as a director for Vyaire, Outset Medical and Therox, and has previously served as a director for Thoratec Corporation, Conceptus, ZELTIQ Aesthetics, Intuitive Surgical, Kyphon and a number of privately held medical device companies. ■